Search results
Results from the WOW.Com Content Network
This page was last edited on 3 February 2025, at 20:23 (UTC).; Text is available under the Creative Commons Attribution-ShareAlike 4.0 License; additional terms may apply.
For premium support please call: 800-290-4726 more ways to reach us
Capri is the parent company of Kors' eponymous brand, as well as Versace and Jimmy Choo. Tapestry, owner of Coach New York and Kate Spade, offered to buy Capri for $8.5 billion in 2023, [7] [8] but called off the acquisition after it was blocked by a federal judge the following year. [9]
Technology companies based in San Diego (1 C, 19 P) Pages in category "Companies based in San Diego" The following 200 pages are in this category, out of approximately 251 total.
Verenium Corporation was a San Diego, California-based industrial biotechnology company founded in 2007 as the result of a merger between Diversa (San Diego) and Celunol (Cambridge, MA). [ 2 ] [ 3 ] The company specialized in research and development for the production of high performance enzymes used in industrial applications, including ...
S&P MidCap 400 constituent LKQ Corp. (NASD:LKQ) will replace Airgas Inc. (NYSE:ARG) in the S&P 500. Air Liquide SA acquired Airgas. [256] May 12, 2016: TXRH: Texas Roadhouse: ALK: Alaska Air Group: S&P 500 constituent Western Digital Corp. (NASD:WDC) is acquiring SanDisk Corp. in a deal expected to be completed on or about that date pending ...
DiamondRock Hospitality Company Real Estate Hotel & Resort REITs Bethesda, Maryland: view: 0001298946 DRQ: Dril-Quip Inc. Energy Oil & Gas Equipment & Services Houston, Texas: view: 0001042893 DV: DoubleVerify Holdings, Inc. Information Technology Application Software New York City, New York: view: 0001819928 DVAX: Dynavax Technologies Corp ...
Ligand Pharmaceuticals Incorporated is a biopharmaceutical company located in San Diego, California. [4] Founded in 1987 as Progenix Inc., the company went public in 1992.. Initially focused on developing its own drugs, a period of turbulence in the early 2000s culminated in its CEO being ejected by the shareholders and provoked a change in focus to the acquisition of existing drugs and ...